Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sutro Biopharma (STRO) Amortizatization of Intangibles (2017 - 2025)

Historic Amortizatization of Intangibles for Sutro Biopharma (STRO) over the last 9 years, with Q3 2025 value amounting to $755000.0.

  • Sutro Biopharma's Amortizatization of Intangibles fell 7200.59% to $755000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year decrease of 6044.69%. This contributed to the annual value of $9.7 million for FY2024, which is 709.64% up from last year.
  • As of Q3 2025, Sutro Biopharma's Amortizatization of Intangibles stood at $755000.0, which was down 7200.59% from $1.0 million recorded in Q2 2025.
  • Sutro Biopharma's 5-year Amortizatization of Intangibles high stood at $3.1 million for Q4 2023, and its period low was -$799000.0 during Q4 2021.
  • Moreover, its 5-year median value for Amortizatization of Intangibles was $1.1 million (2025), whereas its average is $1.0 million.
  • As far as peak fluctuations go, Sutro Biopharma's Amortizatization of Intangibles crashed by 130975.61% in 2021, and later skyrocketed by 222427.18% in 2023.
  • Quarter analysis of 5 years shows Sutro Biopharma's Amortizatization of Intangibles stood at -$799000.0 in 2021, then soared by 246.93% to $1.2 million in 2022, then soared by 160.05% to $3.1 million in 2023, then plummeted by 49.59% to $1.5 million in 2024, then tumbled by 50.94% to $755000.0 in 2025.
  • Its last three reported values are $755000.0 in Q3 2025, $1.0 million for Q2 2025, and $1.1 million during Q1 2025.